Step by step Lipkin’s metabolomic study produces a coherent picture of mitochondrial dysfunction The really neat thing about Ian Lipkin’s latest work on ME/CFS is how well all the results fit together. Health Rising reported on the preprint of this...
Ron Davis gets a win but will he ever be given the chance to bring his core disrupting technologies to ME/CFS? An ME/CFS Moment: something unexpected happens that indicates the tide is rising for the ME/CFS field. This could include something like a big grant...
An $8 million clinical trial of a mitochondrial enhancer, no less, in ME/CFS? I thought I was hearing things but it was so, and, in the end, it even makes sense given how rapidly some parts of this field are moving forward. But first, a little backstory. A...
Frustrated for 10 years in his desire to study ME/CFS, Paul Fisher of LaTrobe University in Australia made the most of it when he got the chance He and his lead researcher on these studies, Daniel Missailidis, have rolled off four studies and two reviews in the last...
It took a muscle biopsy to uncover it but there it was – strong evidence, apparently, of a bona fide mitochondrial deficiency in some people with fibromyalgia (FM). Julian Ambrus, the senior author of this paper has published widely in and developed an animal...
The title of this metabolomic study “Evidence for Peroxisomal Dysfunction and Dysregulation of the CDP-Choline Pathway in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome” made it clear that something new was in the works. Peroxisomal dysfunction had...